2023 Form 5500 filing — Xellia Pharmaceuticals 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240923065327NAL0006480963001) for Xellia Pharmaceuticals 401(K) Plan, reported by Xellia Pharmaceuticals Usa LLC under EIN 47-1150410 and plan number 001. It reports 457 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20240923065327NAL0006480963001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Xellia Pharmaceuticals Usa LLC
- EIN
- 47-1150410
- Plan number
- 001
- Location
- Buffalo Grove, IL
- Participants
- 457
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $22,532,767
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $22,532,767
- Employer contributions
- $1,102,629
- Participant contributions
- $2,613,946
- Total income / additions
- $7,806,185
- Benefits paid
- $2,509,506
- Administrative expenses
- $80,380
- Total expenses
- $2,634,010
- Net increase / (decrease)
- $5,172,175
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Fidelity Workplace Services LLC | PLAN ADMINISTRATOR | $55,380 | $0 |
| Gallagher Fiduciary Advisors LLC | ADVISOR | $25,000 | not reported in the loaded dataset |